126 related articles for article (PubMed ID: 38767128)
1. Severe dawn phenomenon predicts long-term risk of all-cause mortality in patients with type 2 diabetes.
Cai J; Peng P; Lu J; Shen Y; Wang C; Mo Y; Lu W; Zhu W; Xia T; Zhou J
Diabetes Metab Res Rev; 2024 May; 40(4):e3813. PubMed ID: 38767128
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Complexity of Glucose Time Series on All-Cause Mortality in Patients With Type 2 Diabetes.
Cai J; Yang Q; Lu J; Shen Y; Wang C; Chen L; Zhang L; Lu W; Zhu W; Xia T; Zhou J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1093-1100. PubMed ID: 36458883
[TBL] [Abstract][Full Text] [Related]
3. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?
Monnier L; Colette C; Dejager S; Owens D
Diabetes Care; 2013 Dec; 36(12):4057-62. PubMed ID: 24170753
[TBL] [Abstract][Full Text] [Related]
4. Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.
Lu J; Wang C; Cai J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Hu G; Xia T; Zhou J
J Clin Endocrinol Metab; 2021 Oct; 106(11):3160-3167. PubMed ID: 34279663
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia.
Baretić M; Bralić Lang V
BMC Endocr Disord; 2020 Mar; 20(1):35. PubMed ID: 32151247
[TBL] [Abstract][Full Text] [Related]
6. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
7. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
[TBL] [Abstract][Full Text] [Related]
8. Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: A prospective cohort study.
Mo Y; Wang C; Lu J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Xia T; Zhou J
Diabetes Res Clin Pract; 2022 Jul; 189():109940. PubMed ID: 35662611
[TBL] [Abstract][Full Text] [Related]
9. Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study.
He Q; Gao M; Zhou X; Wang L; Fang Y; Hu R
J Diabetes Investig; 2024 Jul; 15(7):939-945. PubMed ID: 38470086
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study.
Képénékian L; Smagala A; Meyer L; Imhoff O; Alenabi F; Serb L; Fleury D; Dorey F; Krummel T; Le Floch JP; Chantrel F; Kessler L
Clin Nephrol; 2014 Oct; 82(4):240-6. PubMed ID: 25161114
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
12. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
13. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study.
Avari P; Ramli R; Reddy M; Oliver N; Fothergill R
BMC Endocr Disord; 2019 Oct; 19(1):110. PubMed ID: 31655586
[TBL] [Abstract][Full Text] [Related]
14. The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia.
Li C; Ma X; Yin J; Mo Y; Zhang L; Lu J; Lu W; Bao Y; Vigersky RA; Zhou J; Jia W
Diabetes Res Clin Pract; 2020 Aug; 166():108308. PubMed ID: 32650035
[TBL] [Abstract][Full Text] [Related]
15. Association of high circulating testosterone with increased glycaemic variability in type 2 diabetes: A cross-sectional study in China.
Ding B; Sun R; Zhai XF; Lu TT; Cheng L; Li FF; Hu Y; Ma JH
Diabetes Metab Res Rev; 2019 May; 35(4):e3126. PubMed ID: 30614187
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
[TBL] [Abstract][Full Text] [Related]
17. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
Mayeda L; Katz R; Ahmad I; Bansal N; Batacchi Z; Hirsch IB; Robinson N; Trence DL; Zelnick L; de Boer IH
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958307
[TBL] [Abstract][Full Text] [Related]
18. Risk of major cardiovascular events, severe hypoglycaemia, and all-cause mortality for users of insulin degludec versus insulin glargine U100-A Danish cohort study.
Jensen MH; Hejlesen O; Vestergaard P
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3225. PubMed ID: 31647163
[TBL] [Abstract][Full Text] [Related]
19. Glycemic Measures and Risk of Mortality in Older Chinese: The Guangzhou Biobank Cohort Study.
Jiang CQ; Xu L; Lam TH; Jin YL; Sen Zhang W; Zhu F; Thomas GN; Cheng KK
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31679008
[TBL] [Abstract][Full Text] [Related]
20. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
Bonds DE; Miller ME; Bergenstal RM; Buse JB; Byington RP; Cutler JA; Dudl RJ; Ismail-Beigi F; Kimel AR; Hoogwerf B; Horowitz KR; Savage PJ; Seaquist ER; Simmons DL; Sivitz WI; Speril-Hillen JM; Sweeney ME
BMJ; 2010 Jan; 340():b4909. PubMed ID: 20061358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
